Russell Investments Group’s XBiotech XBIT Stock Holding History

Russell Investments Group’s Portfolio XBIT Stock Details XBIT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-1,425	Closed	-$4.23K	–	4235
2025 Q2	$4.23K	Buy	+1,425	New	+$4.14K	﹤0.01%	3484
2022 Q2	–	Sell	-1,023	Closed	-$8K	–	2977
2022 Q1	$8K	Hold	1,023	–	–	﹤0.01%	2719
2021 Q4	$11K	Hold	1,023	–	–	﹤0.01%	2974
2021 Q3	$13K	Hold	1,023	–	–	﹤0.01%	3013
2021 Q2	$16K	Sell	1,023 -118,441	-99%	-$2.01M	﹤0.01%	3179
2021 Q1	$2.05M	Buy	119,464 +69,369	+138%	+$1.3M	﹤0.01%	1865
2020 Q4	$784K	Sell	50,095 -68,652	-58%	-$1.27M	﹤0.01%	2229
2020 Q3	$2.27M	Buy	118,747 +5,952	+5%	+$103K	﹤0.01%	1605
2020 Q2	$1.55M	Buy	112,795 +8,952	+9%	+$126K	﹤0.01%	1790
2020 Q1	$1.1M	Buy	103,843 +47,598	+85%	+$775K	﹤0.01%	1792
2019 Q4	$1.05M	Buy	+56,245	New	+$724K	﹤0.01%	2072

Other funds holding XBIT

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

RBF Capital San Francisco, California $2.05B AUM 29.64% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Squarepoint New York $85.1B AUM 20.93% 1-Year Est. Return

Russell Investments Group's XBIT Position: Q3 2025 in Review

Russell Investments Group sold out of XBiotech (XBIT) in Q3 2025, closing a stake of 1,425 shares — an estimated $4.23K sold.

Russell Investments Group first reported a position in XBIT in Q4 2019 and held it in 11 quarters. The position peaked at $2.27M in Q3 2020. 48 funds tracked by Wall St. Rank hold XBIT as of Q3 2025.

Russell Investments Group reported no remaining XBiotech position as of Q3 2025 after selling out during the quarter.
Russell Investments Group sold 1,425 XBiotech shares in Q3 2025, an estimated $4.23K.
Russell Investments Group first reported a position in XBiotech in Q4 2019 and held it in 11 quarters.
Russell Investments Group's XBiotech position peaked at $2.27M in Q3 2020.
48 funds tracked by Wall St. Rank held XBiotech as of Q3 2025.

Based on Russell Investments Group's 13F filing for Q3 2025, filed 13 Nov 2025.